Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP4K4 | O95819 | 1/20 | 0.44 |
| ▸ | L3MBTL3 | Q96JM7 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | IRAK4 | Q9NWZ3 | 6/20 | 0.43 |
| ▸ | PRKDC | P78527 | 5/20 | 0.43 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.42 |
| ▸ | BMPR1B | O00238 | 1/20 | 0.42 |
| ▸ | BMPR1A | P36894 | 1/20 | 0.42 |
| ▸ | ACVR1B | P36896 | 1/20 | 0.42 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.42 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | TTK | P33981 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2419166 | 0.87 | PRKDC (0.53) | L3MBTL1PRKDC | |
| SCHEMBL31302322 | 0.87 | PRKDC (0.53) | L3MBTL1PRKDC | |
| SCHEMBL8871292 | 0.76 | PRKDC (0.50) | PRKDC | |
| SCHEMBL17420298 | 0.74 | PIM2 (0.53) | L3MBTL3L3MBTL1IRAK4PIM2 | |
| SCHEMBL23123960 | 0.72 | QPCT (0.54) | L3MBTL3L3MBTL1TTK | |
| SCHEMBL20248043 | 0.72 | L3MBTL3 (0.51) | L3MBTL3L3MBTL1BMPR1BBMPR1AACVR1B | |
| SCHEMBL419985 | 0.71 | MAPT (0.43) | L3MBTL3L3MBTL1BMPR1BBMPR1AACVR1B | |
| SCHEMBL2723240 | 0.71 | L3MBTL3 (0.50) | MAP4K4L3MBTL3L3MBTL1BMPR1BBMPR1A | |
| SCHEMBL16427580 | 0.71 | CHRNB2 (0.51) | L3MBTL3L3MBTL1BMPR1BBMPR1AACVR1B | |
| SCHEMBL29437377 | 0.71 | L3MBTL3 (0.50) | MAP4K4L3MBTL3L3MBTL1BMPR1BBMPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240246940-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | VORONOI INC. (KR) | 2024-07-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240246940-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | ERBB2, EGFR, ERBB3 | MAP4K4 548/4885L3MBTL3 3253/4885L3MBTL1 3563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.